Bausch + Lomb Announces Results from First Phase 3 Trial of NOV03

Bausch + Lomb and Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, announced statistically significant topline data from the first Phase 3 trial (GOBI trial) evaluating the investigational drug NOV03 (perfluorohexyloctane) as a first-in-class eye drop with a novel mechanism of action to treat the signs and symptoms of dry eye disease (DED) associated with meibomian gland dysfunction (MGD).

The GOBI trial met both of its co-primary endpoints, including:

  • Change from baseline in total Corneal Fluorescein Staining (tCFS), a measure of assessing damage to the eye, achieved statistical significance at day 15 (secondary endpoint), with continued results through day 57 (primary endpoint) compared to control;
  • Change from baseline in dryness score achieved statistical significance at day 15 (secondary endpoint), with continued results through day 57 (primary endpoint) compared to control, as rated on a visual analogue scale (VAS) ranging from 0-100 (0 = no discomfort; 100 = maximum discomfort).

The GOBI trial also met all of its secondary endpoints, showing statistically significant improvements in both the signs and symptoms of DED associated with MGD that were studied.

“There is currently no pharmaceutical therapy available in the United States for the treatment of dry eye disease associated with meibomian gland dysfunction,” said Yolande Barnard, vice president and general manager, U.S. Pharmaceuticals, Bausch + Lomb. “These outstanding topline results are very encouraging that we may be able to bring this first-in-class treatment option to market for the millions of patients who have dry eye disease associated with meibomian gland dysfunction.”

“I am very impressed by the positive results from this first Phase 3 study of NOV03, in particular the findings at day 15 in treating the signs and symptoms of the disease,” said Joseph Tauber, M.D., founder of Tauber Eye Center in Kansas City, Mo., and trial investigator. “These findings validate the importance of the continued development of NOV03, and I look forward to seeing additional results from the Phase 3 program.”

The Phase 3 program for NOV03 includes an ongoing second Phase 3, multi-center, randomized, double-masked, saline-controlled trial (MOJAVE study) and a multi-center, open-label, single-arm 12-month safety extension trial (KALAHARI study). Topline results from MOJAVE, if positive, will allow for a filing to the U.S Food and Drug Administration in 2022.

Click HERE for the full press release.

Related:
Bausch Advances Novel Dry Eye Therapeutic to Phase 3

Featured Posts

Memory of Maria Luisa Pramaor: Founder, Guiding Light, and Heart of Blackfin

On Friday, September 22, Blackfin heartbreakingly and suddenly bereaved of Maria Luisa Pramaor.

Learn More

Ray-Ban and Meta Launch Next Generation of Smart Glasses

The new Ray-Ban I Meta smart glasses features Meta AI, advanced audio and camera capabilities, design customization opportunities, and expanded European distribution

Read more

MIDO Opens CSE Award application and Visitor Registration

MIDO exhibitors can apply to participate in the Certified Sustainable Eyewear (CSE) Award, and registration is now open.

Read more

PPG, Flō-Optics Announce Exclusive Supplier Agreement for First Digitally Applied Optical Coatings

3D printing featuring PPG HI-GARD lens coatings provides durability, scratch resistance

Read more

Creating a Positive Contact Lens Culture Requires Multifactorial Approach, Says New Research Previewed at VEW

Contact Lens Institute™ & The Vision Council Offer Sneak Peek at Forthcoming Report

Read more

Memory of Maria Luisa Pramaor: Founder, Guiding Light, and Heart of Blackfin

On Friday, September 22, Blackfin heartbreakingly and suddenly bereaved of Maria Luisa Pramaor.

Learn More

Ray-Ban and Meta Launch Next Generation of Smart Glasses

The new Ray-Ban I Meta smart glasses features Meta AI, advanced audio and camera capabilities, design customization opportunities, and expanded European distribution

Read More

MIDO Opens CSE Award application and Visitor Registration

MIDO exhibitors can apply to participate in the Certified Sustainable Eyewear (CSE) Award, and registration is now open.

Read More

PPG, Flō-Optics Announce Exclusive Supplier Agreement for First Digitally Applied Optical Coatings

3D printing featuring PPG HI-GARD lens coatings provides durability, scratch resistance

Read More

Creating a Positive Contact Lens Culture Requires Multifactorial Approach, Says New Research Previewed at VEW

Contact Lens Institute™ & The Vision Council Offer Sneak Peek at Forthcoming Report

Read More

Memory of Maria Luisa Pramaor: Founder, Guiding Light, and Heart of Blackfin

On Friday, September 22, Blackfin heartbreakingly and suddenly bereaved of Maria Luisa Pramaor.

Learn More

Ray-Ban and Meta Launch Next Generation of Smart Glasses

The new Ray-Ban I Meta smart glasses features Meta AI, advanced audio and camera capabilities, design customization opportunities, and expanded European distribution

Read more

MIDO Opens CSE Award application and Visitor Registration

MIDO exhibitors can apply to participate in the Certified Sustainable Eyewear (CSE) Award, and registration is now open.

Read more

PPG, Flō-Optics Announce Exclusive Supplier Agreement for First Digitally Applied Optical Coatings

3D printing featuring PPG HI-GARD lens coatings provides durability, scratch resistance

Read more

Creating a Positive Contact Lens Culture Requires Multifactorial Approach, Says New Research Previewed at VEW

Contact Lens Institute™ & The Vision Council Offer Sneak Peek at Forthcoming Report

Read more

Memory of Maria Luisa Pramaor: Founder, Guiding Light, and Heart of Blackfin

On Friday, September 22, Blackfin heartbreakingly and suddenly bereaved of Maria Luisa Pramaor.

Learn More

Ray-Ban and Meta Launch Next Generation of Smart Glasses

The new Ray-Ban I Meta smart glasses features Meta AI, advanced audio and camera capabilities, design customization opportunities, and expanded European distribution

Read more

MIDO Opens CSE Award application and Visitor Registration

MIDO exhibitors can apply to participate in the Certified Sustainable Eyewear (CSE) Award, and registration is now open.

Read more

PPG, Flō-Optics Announce Exclusive Supplier Agreement for First Digitally Applied Optical Coatings

3D printing featuring PPG HI-GARD lens coatings provides durability, scratch resistance

Read more

Creating a Positive Contact Lens Culture Requires Multifactorial Approach, Says New Research Previewed at VEW

Contact Lens Institute™ & The Vision Council Offer Sneak Peek at Forthcoming Report

Read more